NotizieAssistito da IA

Romania's Direct Pharma expands its base to Bulgaria, to enter Moldova

Direct Pharma expands to Bulgaria, plans Moldova entry; aims for 10% growth, €50M turnover target.

Mrudula Kulkarni
Di Mrudula Kulkarni
Caporedattore - Pharma Now
5 lug 2024Updated Jun 26, 2025 · 2 min di lettura
Romania's Direct Pharma expands its base to Bulgaria, to enter Moldova
https://www.facebook.com/DirectPharmaLogistics/?locale=gl_ES
Giornalismo assistito da IA
Reviewed by Mrudula Kulkarni, Caporedattore - Pharma Now

Romania's Direct Pharma Logistics group is expanding its pharmaceutical distribution operations into Bulgaria through a partnership with Sofia-based distributor Medex, according to Romanian media.

Additionally, the group has plans to enter the Moldovan market next year, as reported by Forbes.ro on Wednesday.

This expansion is part of Direct Pharma's strategy to increase its annual turnover by at least 10%, aiming to reach a target of 50 million euros ($54 million).

"For our manufacturing partners, the key benefit is easier access to new neighboring markets where they currently have no presence," said Direct Pharma Logistics co-founder Octavian Iacob, as quoted by Forbes.ro.

In the first quarter of 2024, Direct Pharma Logistics reported a turnover of 11.1 million euros, a 13% increase compared to the same period last year.

The Direct Pharma Logistics group, which includes Direct Pharma Logistics, Pharmalink, and Farmatop, has over 18 years of experience in pharmaceutical logistics, specializing in pre-wholesale, wholesale, and retail distribution of medicines.

Medex, based in Sofia, is an authorized distributor of products from Bayer, La Roche, Sanofi, Pfizer, Mundipharma, Merck, and Nobel Pharma, among others.

 

 

 

ArgomentiNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Caporedattore - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Caricamento della discussione…

Altro da Pharma News

Tutti gli articoli →